Tasectan and Xilaplus in the new German GPGN Guidelines
https://noventure.com/tasectan-and-xilaplus-in-the-new-german-gpgn-guidelines/#:~:text=German%20GPGN%20Guidelines-,Tasectan%20and%20Xilaplus%20in%20the%20new%20German%20GPGN%20Guidelines,-Z%20Gastroenterol%202024
Z Gastroenterol 2024; 62(09): 1574-1643
Getting into treatment guidelines is lengthy, especially for new products that need time to gather sufficient scientific and real-life evidence.
For this reason, we are glad to announce that Noventure´s mucoprotectants gelatin tannate and xyloglucan have been mentioned on good terms in the new guideline of the German Society for Pediatric Gastroenterology and Nutrition, “Acute infectious gastroenteritis in infants, children, and adolescents“*.
This constitutes a great milestone in our long-term goal to have Tasectan and Xilaplus recognized in the guidelines of international medical societies.
* Z Gastroenterol 2024; 62(09): 1574-1643
